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Repolarization of the mammalian heart action potential is a very important physiological variable. It sets action-potential duration and thus strongly modulates contractility and refractoriness in both the atria and the ventricles. Repolarization is initiated and controlled by the time-and voltage-dependent onset of a variety of different outward potassium (K + ) currents, some of which are highly non-linear. 1 One of these currents, the so-called slow outward delayed rectifier, or I Ks , is expressed in the human ventricle. Its activation adds to the safety factor for repolarization (the so-called repolarization reserve) through its intrinsic time and voltage dependence. This is prominent following augmentation of I Ks by sympathetic nerve stimulation.
2
A paper in this issue from the McDonald laboratory 3 confirms and extends what is known about the modulation of I Ks in response to changes in osmotic strength of the external medium. A significant change in osmotic strength (+20 -30%) may take place in the setting of ischaemia-reperfusion of the heart. This paper demonstrates relatively rapid (3-5 min to steady state) changes in I Ks in single ventricular myocytes obtained from the hearts of adult guinea pigs in response to alterations in osmotic strength: reductions result in reversible increases in I Ks and vice versa. These changes appear to be quite selective as judged by the reported lack of effect on a selected K + current denoted HERG.
The context for these findings and some aspects of their interpretation is aided by the quite detailed molecular information on the protein subunits which are responsible for the K + -selective channels that underlie I Ks . 4 The pore-forming a-subunit has been identified as KCNQ1 in the human heart, and a number of the important properties of this conductance are conferred by the stoichiometric and essential association of a b-subunit, denoted KCNE1, with KCNQ1. 5, 6 Similar K + currents have been identified in a variety of mammalian tissues. These include a number of epithelial cells where they participate in secretory processes (see Jespersen et al. 7 for review). In some Cl 2 -secreting epithelia, complexes formed by KCNQ1 and KCNEx b-subunits are localized in the basolateral membranes of the epithelial cells. This is the case with airway epithelia, 8 small and large intestinal epithelia, and pancreatic acinar cells. 9 Activation of KCNQ1 results in hyperpolarization of these cells, and this enhances the driving force for Cl 2 secretion on the apical surface. In the epithelia where KCNQ1 is localized on the apical side, its function is different. In the kidney proximal tubule, activation of KCNQ1 hyperpolarizes the apical membrane, which enhances the driving force for Na + reabsorption. 10 In the acid-secreting cells of the stomach, activation of I Ks is a means to recycle the intracellular K + that has accumulated due to the activity of the apical K + /H + exchangers. 11 In the marginal cells of the inner ear, I Ks actively secretes K + into the endolymph, which is an essential function for normal hearing. 12, 13 It is known that point mutations in either KCNQ1 or KCNE1 can result in marked changes in the macroscopic K + current. Some of these mutations have been demonstrated to contribute to actionpotential lengthening and to a form of the pro-arrhythmic (long Q-T) syndrome. In the case of the Jervell and Lange-Nielsen syndrome, one such mutation affects both heart rhythm and hearing, as a consequence of the dual but tissue-specific expression of the altered gene product KCNQ1. 13 One way of beginning to understand the consequences of the osmolyte-induced changes in I Ks reported by Missan et al. 3 is to mathematically reconstruct the human ventricular action potential. This provides a useful visual comparison of the control action-potential waveform with the action potential computed after the experimentally observed osmolyte-induced changes in I Ks have been introduced as input parameters. Figure 1 compares a control action potential (continuous line) with an action potential computed, following a 50% decrease in I Ks (assumed hypertonic challenge, dashed line) and a two-fold increase in I Ks (assumed hypotonic challenge, dotted line). As expected from the known role of I Ks , the action-potential duration is changed somewhat. These moderate changes reflect the fact that under control (basal) conditions, the contribution of I Ks to the net repolarizing outward current is quite small (10-15% of total). In the setting of enhanced activity (tone) of the sympathetic neuron (e.g. some type of heart failure), sympathetic tone is enhanced and an action of norepinephrine on b-receptors linked to I Ks can
The opinions expressed in this article are not necessarily those of the Editors of Cardiovascular Research or of the European Society of Cardiology.
enhance this current quite significantly. At a fixed heart rate, these changes could alter both excitability and refractoriness. The altered action-potential waveform could also be reflected as a change in the Q-T interval of the ECG, depending on the exact location of the change in osmotic strength, e.g. epi-vs. endocardium. From the data presented and previous publications, it is clear that changes in osmotic strength can have significant effects on the magnitude of I Ks . However, the underlying mechanism(s) remain to be resolved. For example, the results do not address whether the I Ks response is due to stretch of the sarcolemma in the setting of hypotonic challenge or whether this K + channel complex is otherwise sensitive to osmotic challenge. 14 17, 18 In this regard, data showing changes in cell volume or capacitance as a function of time would be instructive. In summary, it is now clear that I Ks is a major target for osmotic stress. 3, 19 This is likely to have important consequences in the setting of ischaemia-reperfusion and perhaps also during cardioplegia applications or dialysis procedures.
